Marie‐France Moreau

Phase II scintigraphic clinical trial of malignant melanoma and metastases with iodine-123-N-(2-diethylaminoethyl 4-iodobenzamide).

J. Michelot, Marie‐France Moreau, A. Veyre et al. · PubMed · 1993 · 119 citations

Primary Melanomas, Surgical Oncology, Engineering +15

Synthesis and evaluation of new iodine-125 radiopharmaceuticals as potential tracers for malignant melanoma.

J. Michelot, Marie‐France Moreau, P.G. Labarre et al. · PubMed · 1991 · 89 citations

Engineering, Malignant Melanoma, New Iodine-125 Radiopharmaceuticals +18

123 I- N -(2-diethylaminoethyl)-2-iodobenzamide: a potential imaging agent for cutaneous melanoma staging

Nicole Moins, M. D’Incan, J. Bonafous et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2002 · 72 citations

Potential Imaging Agent, I- N, Engineering +13

Detection of Simian Immunodeficiency Virus in Semen, Urethra, and Male Reproductive Organs during Efficient Highly Active Antiretroviral Therapy

Giulia Matusali, N Dereuddre-Bosquet, Anna Le Tortorec et al. · Journal of Virology · 2015 · 53 citations · Full text

Synthesis, characterization and comparative biodistribution study of a new series of p -Iodine-125 benzamides as potential melanoma imaging agents

Nicole Moins, Janine Papon, Hélène Seguin et al. · Nuclear Medicine and Biology · 2001 · 49 citations

Medicinal Chemistry, Engineering, P -Iodine-125 Benzamides +12